First registration trial of tenapanor to treat hyperphosphatemia in ESRD patients on dialysis
Phase of Trial: Phase III
Latest Information Update: 08 Aug 2016
At a glance
- Drugs Tenapanor (Primary)
- Indications Hyperphosphataemia
- Focus Registrational; Therapeutic Use
- 08 Aug 2016 According to an Ardelyx media release, results from this trial are expected in the first quarter of 2017.
- 08 Aug 2016 According to an Ardelyx media release, status changed from planning to recruiting.
- 20 Jul 2016 New trial record